ChemicalBook > Product Catalog >API >Antineoplastic agents >Tinib Antineoplastic drugs >4-QuinazolinaMine, N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-Methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-, (2E)-2-butenedioate (1:2)

4-QuinazolinaMine, N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-Methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-, (2E)-2-butenedioate (1:2)

Request For Quotation
4-QuinazolinaMine, N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-Methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-, (2E)-2-butenedioate (1:2) Suppliers list
Company Name: Shanghai Fuhe Chemistry Technology Co., Ltd.  
Tel: 0086-21-67651709
Email: cfx759@hotmail.com
Company Name: NCE Biomedical Co.,Ltd.  
Tel: 4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988
Email:
Company Name: Sichuan Yuehe Bio-Pharmaceutical Co.,Ltd  
Tel: 028-82729560 17365561851
Email: tangzhichen@yuehepharm.com
Company Name: SPIRO PHARMA  
Tel:
Email: eric_feng1954@126.com
Company Name: Shanghai EFE Biological Technology Co., Ltd.  
Tel: 021-65675885 18964387627
Email: info@efebio.com

4-QuinazolinaMine, N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-Methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-, (2E)-2-butenedioate (1:2) manufacturers
4-QuinazolinaMine, N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-Methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-, (2E)-2-butenedioate (1:2) Basic information
Product Name:4-QuinazolinaMine, N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-Methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-, (2E)-2-butenedioate (1:2)
Synonyms:4-QuinazolinaMine, N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-Methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-, (2E)-2-butenedioate (1:2);Saracatinib difuMarate;N-(5-Chloro-1,3-benzodioxol-4-yl)-7-[2-(4-Methyl-1-piperazinyl)ethoxy]-5-(tetrahydro-2H-pyran-4-yloxy)-4-quinazolinaMine (2E)-2-butenedioate (1:2);AZD 0530 difumarate - Saracatinib;Saracatinib Fumarate
CAS:893428-72-3
MF:C31H36ClN5O9
MW:658.11
EINECS:641-395-5
Product Categories:
Mol File:893428-72-3.mol
4-QuinazolinaMine, N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-Methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-, (2E)-2-butenedioate (1:2) Structure
4-QuinazolinaMine, N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-Methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-, (2E)-2-butenedioate (1:2) Chemical Properties
form Solid
color Off-white to light yellow
Safety Information
MSDS Information
4-QuinazolinaMine, N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-Methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-, (2E)-2-butenedioate (1:2) Usage And Synthesis
UsesSaracatinib (AZD0530) difumarate is a potent Src inhibitor with IC50 values of 2.7-11 nM for c-Src, Lck, c-YES, Lyn, Fyn, Fgr and Blk, and is selective for other tyrosine kinases. [1].
References[1] Green TP, et al. Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530. Mol Oncol, 2009, 3(3), 248-261. DOI:10.1016/j.molonc.2009.01.002
4-QuinazolinaMine, N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-Methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-, (2E)-2-butenedioate (1:2) Preparation Products And Raw materials
Tag:4-QuinazolinaMine, N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-Methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-, (2E)-2-butenedioate (1:2)(893428-72-3) Related Product Information
Tirbanibulin SU 6656 Protein Tyrosine Kinase Compound Library Anti-cancer compound library A 419259 trihydrochloride PP2